Hansen Pharma Buys 80% Interest in Yongzitang Pharma for $45 Million
by Richard Daverman, PhD
November 5, 2013 -- Hunan Hansen Pharmaceutical will pay 282 million RMB ($44.8 million) to purchase an 80% stake in Yunnan Yongzitang Pharmaceutical, a fellow TCM company. Yongzitang, whose major product is rhizome gastrodiae capsules, owns seven national exclusive TCM patents, five of which have national IP. The company reported 10 million RMB ($1.6 million) in profit during the first nine months of 2013. More details....
Stock Symbol: (SHE: 002412)
Help employers find you! Check out all the jobs and post your resume.
